Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Microbiology Spectrum|June 16, 2026
DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanismHideo Takayama, Kouki Nio, Kazuyuki Kuroki, et al.
Oncotarget|June 8, 2017
Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat dietHikari Okada, Riuta Takabatake, Masao Honda, et al.
Internal Medicine (Tokyo, Japan)|July 26, 2023
Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab: Different Clinical Course in the Colon and Gastroduodenal LesionsTomoyuki Hayashi, Takeshi Terashima, Masaki Nishitani, et al.
Journal of Gastroenterology|August 30, 2017
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis BKazunori Kawaguchi, Masao Honda, Hajime Ohta, et al.
Cell Death & Disease|April 19, 2025
Transcription factor JUNB is required for transformation of EpCAM-positive hepatocellular carcinoma (HCC) cells into CD90-positive HCC cells in vitroYutaro Kawakami, Hikari Okada, Kouki Nio, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2018
Unexpected Replication Boost by Simeprevir for Simeprevir-Resistant Variants in Genotype 1a Hepatitis C VirusKazuhisa Murai, Tetsuro Shimakami, Christoph Welsch, et al.
Scientific Reports|February 9, 2019
Notch signaling facilitates hepatitis B virus covalently closed circular DNA transcription via cAMP response element-binding protein with E3 ubiquitin ligase-modulationZijing Wang, Kazunori Kawaguchi, Masao Honda, et al.
Journal of Gastroenterology|February 2, 2019
Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitisMasataka Kanno, Kazunori Kawaguchi, Masao Honda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 11, 2023
Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplificationMakoto Yamamoto, Takeshi Terashima, Tatsuya Yamashita, et al.
Hepatology (Baltimore, Md.)|June 26, 2014
Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathwayTakayoshi Shirasaki, Masao Honda, Tetsuro Shimakami, et al.
Pageof 12